Global HIV, Hepatitis and STIs Programmes
The Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes leads the development and implementation of the global health sector strategy on the elimination of the diseases as public health threats.
HIV guidelines
Latest guidelines
22 July 2024
Guidelines for HIV post-exposure prophylaxis
WHO’s updated PEP guidelines prioritize broader access to PEP, including community-based delivery and task sharing to mitigate barriers such as stigma...
These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...
More HIV guidelines
22 July 2024
Guidelines for HIV post-exposure prophylaxis
Despite advancements in testing and treatment, over one million people became infected with HIV in 2022. This warrants a need for a revitalized focus on...
These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...
17 July 2024
Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema...
The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis...
29 July 2022
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response...
29 July 2022
Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact
As the HIV response moves to focusing on closing the remaining gaps in prevention, testing and treatment services, an evolution in the underlying routine...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people...
It is a priority for WHO to ensure that products are developed in a manner that supports optimal use globally, including in low- and middle-income...
27 June 2022
Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to...
7 June 2022
WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical...
HIV guidelines apps
Technical information on HIV
